Heterogeneity of regulatory B cells in autoimmune diseases: implications for immune equilibrium and therapeutic strategies. [PDF]
Yan H, He J, Lin X.
europepmc +1 more source
Circulating CD16-Positive Monocyte-like Myeloid-Derived Suppressor Cells and Intermediate Monocytes Associated with Clinical and Immunological Complications in Pars Planitis Patients. [PDF]
Kosmaczewska A +7 more
europepmc +1 more source
CTLA-4 expression on tregs is needed for suppression of autoimmune uveitis. [PDF]
Ahn M, Dostal J, Hegde P, Lee DJ.
europepmc +1 more source
Th17 cell pathogenicity in autoimmune disease. [PDF]
Park E, Ciofani M.
europepmc +1 more source
Microarray Analysis of Cytokine and Chemokine Gene Expression after Prednisolone Treatment in Murine Experimental Autoimmune Uveoretinitis [PDF]
ハシダ, ノリヤス, 橋田, 徳康
core
Experimental Autoimmune Uveoretinitis(EAU) in the Mouse
openaire
Related searches:
Everolimus improves experimental autoimmune uveoretinitis
Experimental Eye Research, 2012The efficacy and action mechanism of everolimus in the treatment of experimental autoimmune uveoretinitis (EAU) was analyzed. Disease was induced in B10.RIII mice by immunization with human interphotoreceptor-retinoid-binding protein peptide 161-180 (hIRBPp161-180). Everolimus was administered by oral gavage (5 mg/kg/d) beginning either two days before
Hennig, M. +6 more
openaire +3 more sources
Angiographic abnormalities of experimental autoimmune uveoretinitis
Current Eye Research, 1996Experimental autoimmune uveoretinitis (EAU) is an invaluable animal model for studying inflammatory eye disease in humans. Indocyanine green (ICG) is a fluorescent dye that can be used to image both retinal and choroidal vessels. This study was performed to examined the retinal and choroidal vascular abnormalities of a rat model of EAU using ICG and ...
L J, Howe +4 more
openaire +2 more sources

